Literature DB >> 22449668

Warfarin-induced leukocytoclastic vasculitis: a case report and review of literature.

Chien-Yi Hsu1, Wei-Sheng Chen, Shih-Hsien Sung.   

Abstract

Warfarin is widely prescribed for patients with atrial fibrillation. In addition to unexpected bleeding, allergic skin reaction is one of its uncommon adverse effects. We herein report an 89-year-old man who, after taking warfarin for 4 years, suffered extensive skin eruptions. The skin biopsy disclosed leukocytoclastic vasculitis. The causal relationship between skin lesions and warfarin was confirmed after re-challenge of warfarin. A literature review revealed only 13 such cases reported from 1980 to 2011. Clinicians should be aware of this potential adverse effect of warfarin.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22449668     DOI： 10.2169/internalmedicine.51.6240

Source DB:  PubMed          Journal:  Intern Med        ISSN： 0918-2918            Impact factor:   1.271


  9 in total

1.  Multidrug-related leukocytoclastic vasculitis raising suspicion of sexual homicide-things are not always what they seem.

Authors:  Lucia Tattoli; Klaus Krocker; Julia Sautter; Michael Tsokos
Journal:  Int J Legal Med       Date:  2015-05-10       Impact factor: 2.686

2.  Leukocytoclastic Vasculitis Secondary to Pyridostigmine (Mestinon): Report of a Possible First Case.

Authors:  Gunveen Singh; Tim Hodgson; David E Clarke
Journal:  Perm J       Date:  2016-11-18

3.  Supratherapeutic International Normalized Ratio causing Nephropathy: A Rare Adverse Effect of Warfarin.

Authors:  Muhammad Shabbir Rawala; Amna Saleem Ahmed; Muhammad Y Khan; Muhammad Nauman Riaz; Amr Eltoukhy
Journal:  Cureus       Date:  2019-07-22

4.  Nafcillin implicated in a case of cutaneous and gastrointestinal leukocytoclastic vasculitis.

Authors:  Changqing Xie; Suchita S Pancholi; Niti Armistead
Journal:  J Clin Diagn Res       Date:  2015-04-01

5.  Drug-induced vasculitis: Thiazide or the COVID-19 vaccine, which one is guilty? A case report and literature review.

Authors:  Manoochehr Hekmat; Sepideh Jafari Naeini; Zahra Abbasi; Sahar Dadkhahfar
Journal:  Clin Case Rep       Date:  2022-06-13

Review 6.  Oral anticoagulants and risk of nephropathy.

Authors:  Vinay Narasimha Krishna; David G Warnock; Nakshatra Saxena; Dana V Rizk
Journal:  Drug Saf       Date:  2015-06       Impact factor: 5.606

7.  Cardiovascular and renal protective effects of non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation.

Authors:  Seong Huan Choi; Mina Kim; Hoseob Kim; Dae-Hyeok Kim; Yong-Soo Baek
Journal:  PLoS One       Date:  2022-10-13       Impact factor: 3.752

8.  Complementary Use of U.S. FDA's Adverse Event Reporting System and Sentinel System to Characterize Direct Oral Anticoagulants-Associated Cutaneous Small Vessel Vasculitis.

Authors:  Mohamed Mohamoud; Casie Horgan; Efe Eworuke; Elizabeth Dee; Justin Bohn; Oren Shapira; Monica A Munoz; Danijela Stojanovic; Veronica Sansing-Foster; Adebola Ajao; Lois La Grenade
Journal:  Pharmacotherapy       Date:  2020-11-08       Impact factor: 6.251

9.  Warfarin-induced leukocytoclastic vasculitis and proteinuria.

Authors:  Khalid Jumean; Ahmad Abu Arqoub; Amer Hawatmeh; Firas Qaqa; Ayham Bataineh; Hamid Shaaban
Journal:  J Family Med Prim Care       Date:  2016 Jan-Mar
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.